Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Viewpoint

Vol. 135 No. 1112 (2005)

Reassessment of the benefit/risk-ratio of selective COX-2-inhibitors

  • U Klotz
DOI
https://doi.org/10.4414/smw.2005.11057
Cite this as:
Swiss Med Wkly. 2005;135:166-166
Published
26.03.2005